经典毛发扁平苔藓管理:EADV毛发疾病工作组立场声明
本立场声明由欧洲皮肤病与性病学会(EADV)毛发疾病工作组基于广泛文献综述与专家共识制定,针对经典毛发扁平苔藓(LPP)提出管理建议。LPP为原发淋巴细胞性瘢痕性脱发,主要累及头顶或顶叶头皮,由CD8+细胞毒性T细胞靶向毛囊抗原导致炎症和永久性毛囊损伤。治疗包括局部、系统和介入疗法,一线常为强效局部和病灶内激素,中重度或进展期需系统治疗或联合方案,但缺乏随机对照试验和头对头比较,推荐应个体化。
要点
- 早期诊断和及时干预对减少脱发和防止进展至关重要。
- 一线治疗常为强效局部和病灶内激素,可单用或联合其他疗法。
- 中重度、对局部/病灶内激素抵抗或进展期患者应考虑系统治疗或联合方案。
核心结论
- LPP无治愈方法,治疗应基于疾病活动度、合并症和患者偏好个体化制定。
研究设计与样本
- EADV毛发疾病工作组基于广泛文献综述和集体专家经验制定的立场声明。
主要发现
- LPP是主要累及头顶或顶叶头皮的原发淋巴细胞性瘢痕性脱发,由CD8+细胞毒性T细胞靶向毛囊抗原介导。
- 治疗策略包括局部、系统和介入疗法,一线常为强效局部和病灶内激素。
- 随机对照试验有限,尚无头对头治疗比较。
关键数值与推荐
- 一线治疗常包括强效局部和病灶内激素,可单用或联合其他疗法。
- 中重度疾病、对局部/病灶内激素抵抗或进展性病程的患者应考虑系统治疗或联合方案。
临床怎么用
- 早期诊断和及时干预以尽量减少脱发并防止疾病进展。
- 根据疾病活动度、合并症和患者偏好选择个体化治疗方案。
局限性
- 缺乏随机对照试验,无头对头治疗比较。
- 无治愈性治疗,疾病和治疗反应不可预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia primarily affecting the vertex or parietal scalp. This immune-mediated condition involves mainly CD8+ cytotoxic T cells targeting follicular antigens, causing inflammation and permanent damage to hair follicles. Early diagnosis and prompt intervention are then essential to minimize hair loss and prevent further disease progression. Managing LPP is challenging due to the absence of curative treatments and the unpredictable nature of the disease and treatment responses. This position statement summarizes the results of an extensive literature review analysed through the collective expertise of the European Academy of Dermatology and Venereology (EADV) Task Force on Hair Diseases. Treatment strategies for LPP encompass a range of topical, systemic, and interventional therapies. First-line treatments often include potent topical and intralesional steroids, which can be used alone or in combination with other therapies. For patients with moderate to severe disease, resistance to topical/intralesional steroids, or a progressive disease course, systemic therapy or a combination approach should be considered, tailored to disease activity, comorbidities, and patient preferences. While there is no known cure for LPP, randomized controlled trials are limited and no head-to-head treatment comparisons have been conducted to date, these recommendations should be personalized for each patient.
引用
- Seyed Jafari SM, Starace M, Katoulis A, et al. Management of classic lichen planopilaris: The EADV task force on hair diseases position statement. J Eur Acad Dermatol Venereol. 2026. PMID: 41848299. doi:10.1111/jdv.70379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。